These results indicate that vimentin inhibition in Pbrm1-null PDAC cells reversed the tumor grade from poorly to well-differentiated PDAC, thereby reducing the metastasis of Pbrm1-null PDAC in mice. The gene discussed is VIM; the disease is neoplasm.